Insiders · Profile

Patel Naimish

Chief Medical Officer at CRISPR Therapeutics. Filing since 3 Apr 2025. CIK 0002021679

Company
Date
Role
Action
Shares
Amount
Of holding
29 May 2026
Chief Medical Officer
Sold at will
3,786
$210.58K
16.4%
16 Mar 2026
Chief Medical Officer
Sold at will
3,150
$152.02K
19.3%
29 May 2025
Chief Medical Officer
Sold at will
3,932
$141.32K
39.3%
3 Apr 2025
Chief Medical Officer
Bought
1,508
$49.70K
opened
4 decisions on file.